This article is a retraction of:
RETRACTED: Identification of Early Diagnostic and Prognostic Biomarkers via WGCNA in Stomach Adenocarcinoma
A Retraction of the Original Research Article
Identification of early diagnostic and prognostic biomarkers via WGCNA in stomach adenocarcinoma
By Tan R, Zhang G, Liu R, Hou J, Dong Z, Deng C, Wan S, Lai X and Cui H (2021). Front. Oncol. 11:636461. doi: 10.3389/fonc.2021.636461
The journal retracts the 18 June 2021 article cited above.
Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. As a result, the data and conclusions of the article have been deemed unreliable and the article has been retracted.
This retraction was approved by the Chief Editors of Frontiers in Oncology and the Chief Executive Editor of Frontiers. The authors received a communication regarding the retraction and had a chance to respond. This communication has been recorded by the publisher.
Citation: Frontiers Editorial Office (2024) Retraction: Identification of early diagnostic and prognostic biomarkers via WGCNA in stomach adenocarcinoma. Front. Oncol. 14:1459966. doi: 10.3389/fonc.2024.1459966
Received: 05 July 2024; Accepted: 05 July 2024;
Published: 16 July 2024.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2024 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org